Altimmune's weight-loss drug meets main goal in fatty liver disease trial-February 2024-www.financetom.com

Altimmune's weight-loss drug meets main goal in fatty liver disease trial

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Altimmune's weight-loss drug meets main goal in fatty liver disease trial

Jun 26, 2025 4:51 AM

June 26 (Reuters) - Altimmune ( ALT ) said on Thursday

its experimental obesity drug met the main goal of a mid-stage

trial studying it as a potential treatment for a fatty liver

disease.

(Reporting by Puyaan Singh in Bengaluru; Editing by Devika

Syamnath)

Previous page： Discover Reports Better-Than-Expected Q2 Results: Here's The Details Next page： Day One Biopharmaceuticals Insider Sold Shares Worth $320,226, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Discover Reports Better-Than-Expected Q2 Results: Here's The Details

Jul 17, 2024

Discover Financial Services ( DFS ) reported its second-quarter financial results on Wednesday. Here's a look at the key figures from the report. The Details: Discover reported GAAP earnings of $6.06 per share, beating the estimate of $3.07 per share, and quarterly Net Interest Income (NII) of $3.524 billion. Net interest income for the quarter increased by $347 million, or...

Day One Biopharmaceuticals Insider Sold Shares Worth $320,226, According to a Recent SEC Filing

Jul 17, 2024

04:57 PM EDT, 07/17/2024 (MT Newswires) -- Samuel C. Blackman, Head of R&D, on July 16, 2024, sold 20,000 shares in Day One Biopharmaceuticals ( DAWN ) for $320,226. Following the Form 4 filing with the SEC, Blackman Samuel C. has control over a total of 2,121,081 shares of the company, with 1,121,081 shares held directly and 1,000,000 controlled indirectly....

BRIEF-Mexico's Femsa Enters Agreement To Divest Operations For 8 Bln Pesos

Jul 17, 2024

July 17 (Reuters) - Fomento Economico Mexicano SAB de CV : * SAYS ENTERED DEFINITIVE AGREEMENT WITH MILL POINT CAPITAL LLC TO DIVEST REFRIGERATION, FOOD SERVICE EQUIPMENT OPERATIONS FOR 8 BILLION PESOS ($452.08 MILLION) * MEXICO'S FEMSA SAYS TRANSACTION, SUBJECT TO APPROVALS, EXPECTED TO CLOSE IN NEXT FEW MONTHS Further company coverage: ($1 = 17.6960 Mexican pesos) (Reporting by Mexico...

TriNet Group Names Shea Treadway as Chief Revenue Officer

Jul 17, 2024

04:58 PM EDT, 07/17/2024 (MT Newswires) -- TriNet Group ( TNET ) said late Wednesday that Shea Treadway will be chief revenue officer, effective July 29. Treadway most recently served as the head of distribution for Principal Financial Group, TriNet ( TNET ) said. Price: 109.68, Change: +0.05, Percent Change: +0.05 ...